How Data Intelligence is Driving Vaccine Uptake in Pharma, Webinar

Ekaterina Ser

Global Vaccines Marketing

MSD

Presenting the Slovakia case study and its 40% VCR improvement.

Dr. Oliver Harrison

CEO

Koa Health

Expert in behavioural and digital intelligence, bringing a system-level perspective on engagement and population-level decision-making.

Prof Catherine Weil-Olivier

Leadership Team at CLCI and Professor of Paediatrics

Coalition for Life Course Immunisation

Leading voice in immunisation strategy, policy alignment, and improving vaccine access across Europe.

Barbora Husakova

Regional Marketing & Commercial Operations

MSD

Sharing patterns in VCR challenges and opportunities.

Bleddyn Rees

Deputy Chair

Global Health Connector

A leading figure in global digital health and session chair, guiding discussions across strategy, behaviour and real-world uptake.

William Flanagan

Commercial & Technology Director

OpenSky

Explaining the AI-driven uptake intelligence engine behind the MSD success case.

Welcome & Context Setting

Chair: Bleddyn Rees, Executive Chair, Global Health Connector
- Welcome and scene-setting
- Why vaccine uptake remains a shared challenge for pharma and public health
- How the session will connect policy, behaviour, data, and execution
- Framing the discussion around real-world delivery, not theory
11.00
From Recommendation to Uptake: Why Trust, Simplicity, and System Design Matter in Vaccination Strategy

Speaker: Catherine Weil-Olivier
Board Member, Coalition for Life Course Immunisation
- Why uptake often stalls despite authorisation and availability
- The role of trust, safety perception, and early confidence-building
- How delivery models (schools, primary care, pharmacies) shape outcomes
- Why data visibility and feedback loops are critical for targeting gaps
11.10
Behavior, Data and Digital Health at Population Scale

Speaker: Dr Oliver Harrison, CEO, Koa Health
- How behavioral and contextual factors influence health actions at scale
- The role of digital systems in understanding population behavior
- Lessons from large-scale public-health and digital-health programmes
- Why behavior, data, and system design must be addressed together
11.25
MSD Slovakia HPV Programme: From Global Strategy to Local Impact

Speakers: Barbora Husakova & Katia Ser, MSD
- MSD’s global approach to strengthening vaccine uptake and confidence
- Translating global strategy into local execution in Slovakia
- Using data to identify drivers, barriers, and missed populations
- How targeted interventions improved programme effectiveness
- Outcomes achieved, including a 40%+ year-on-year increase in HPV coverage
11.40
The Technology Behind the Outcome: Identifying What Works - and Why

Speaker: William Flanagan, Director of Technology, OpenSky Data Systems
- Turning fragmented data into actionable intelligence for uptake programmes
- Using AI and analytics to identify drivers, barriers, and leverage points
- Supporting collaboration between pharma and public health teams
- Enabling measurement, learning, and scale across markets
12.00
Panel Discussion & Audience Q&A

Moderated by: Bleddyn Rees

12.15

Despite significant investment in awareness and access initiatives, many markets still face regional variability in vaccine coverage — and internal reporting rarely explains why.

This webinar brings together experts across behavioural science, global immunisation strategy, commercial operations, and AI-enabled analytics to examine:

Why uptake varies across regions, even with strong access
How behavioural and system-level factors influence adoption
How real-world data can guide more effective interventions
How one country achieved a 40% improvement through targeted Market Access actions and an AI-driven insight model

If you’re responsible for improving immunisation outcomes, strengthening Market Access initiatives, or understanding real-world drivers of adoption — this session is essential.